News @ a glance
- HEALTH CANADA CONSULTATION ON MANDATORY REPORTING OF ADVERSE REACTIONS. // Canadian Nurse;Nov2005, Vol. 101 Issue 9, p10
The article reports on the public consultation undertaken by Health Canada on implementing an effective mandatory adverse drug reaction (ADR) reporting system for health professionals in 2005. A discussion paper was published by Heath Canada in order to initiate formal consultation with Canadian...
- Health Canada issues reminder of benzocaine risks. // Reactions Weekly;5/7/2011, Issue 1350, p3
This article reports on the move of Health Canada to remind the people of the risks associated with the use of topical benzocaine.
- Report adverse reactions to Health Canada. // British Columbia Medical Journal;Jun2013, Vol. 55 Issue 5, p233
The article announces that Health Canada is asking people to report a serious or unexpected adverse reaction because of any health product.
- Growing support for the Canada Vigilance Program. // Reactions Weekly;5/1/2010, Issue 1299, p3
The article deals with the 35% increase in the number of domestic reports of suspected adverse drug reactions submitted to Health Canada from 2008 to 2009.
- Health Canada is advising consumers not to use Neophase Formula for Men. // Reactions Weekly;8/12/2006, Issue 1114, p2
The article reports on the advise by Health Canada for consumers not to use Neophase Formula for Men from Vigor Nutriceutical Healthcare Inc., because it contained a modified version of sildenafil which can lead to serious health risks.
- Health Canada update 2010. // Reactions Weekly;7/23/2011, Issue 1361, p4
The article reports that 32,921 domestic adverse reaction cases were disclosed to Health Canada in 2010, with most of the cases involving reactions with pharmaceuticals and biotechnology products.
- Febuxostat associated with DRESS syndrome? // Reactions Weekly;Jun2015, Vol. 1555 Issue 1, p2
The article reports that Health Canada's safety review on the drug febuxostat (Uloric) and its association with agranulocytosis or DRESS syndrome.
- Info on paediatric drug safety released by Health Canada. // Reactions Weekly;1/28/2012, Issue 1386, p3
The article deals with the reports received by Health Canada regarding cardiometabolic adverse events suspected of being related to the use of second-generation antipsychotics in children and adolescents aged 18 years and below.
- International opportunities. // AHA News;7/3/95, Vol. 31 Issue 27, p5
Reports on the American International Health Alliance and the US Agency for International Development's search for partnership projects with universities in health administration and management programs in the United States. Plans for team up with Central European and Eastern European...